Stock listing
Telesis Bio, Inc.
Selected listing: TBIO · OTC · USD · US
Telesis Bio, Inc. (OTC:TBIO), Health Technology. Latest release May 28, 2025: Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™…
- Ticker
- OTC:TBIO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- OTC
- Currency
- USD
About Telesis Bio, Inc.
The company is focused on advancing biotechnology solutions. Telesis Bio aims to innovate and enhance the capabilities of genetic engineering and synthetic biology.
Latest news from Telesis Bio, Inc.
Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis
May 28, 2025
Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis
March 18, 2025
Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
September 9, 2024